China Chemical Pharmaceutical Industry Report, 2007
  • Dec/2007
  • Hard Copy
  • USD $499 $250
  • Pages:47
  • Single User License
    (PDF Unprintable)       
  • USD $499 $250
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $998 $499
  • Hard Copy + Single User License
  • USD $699 $350
      

Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value increased to USD 602 billion in 2005 from USD 21.8 billion in 1970, the annual growth rate amounted to 8.3%, more than doubled to 3.5%, the growth rate of global DGP in the same period. With the further increase of R&D cost for new medicine, it is estimated that the development of company of new medicine will slow down, far slower than the growth pace of generic drug companies, since the patent of a large number of important medicine will end, in addition, all the governments cut down the expense on hygiene. Moreover, due to the further increase of environment protection and cost pressure in the developed regions, it is a trend that the raw material drug production will transfer to China, India etc, which will bring opportunities for the raw material drug companies in China.


Sales and Growth Rate of Global Medicine Market, 1970-2006 (USD in 100 Million) 
 


The development of China's pharmaceutical industry is faster than the average level in the world, and it has maintained the rapid growth in recent years, the CAGR reaching 21% from 2000 to 2005, far higher than 8%, the average level in the world. It is forecasted that the pharmaceutical industry in China will remain the fast growth since the rapid growth of China's macro economy, improvement of urbanization, as well as increasingly aging population. Currently, the pharmaceutical companies in China are small, with a large amount, and with fierce competition of homogenous competition, as well as the whole performance declines, which mainly attribute that companies are in the serious lack of innovation and core competitive advantages.

Sales and Growth Rate of China's Chemical Pharmaceutical Industry, 1999-2007 (RMB in 100 Million) 
 

Sales and Growth Rate of China's Raw Material Drug Industry, 1999-2007 (RMB in 100 Million) 

 


The medical reform makes the medicine industry in China step into the healthier development track. China central government has issued many relevant policies to regulate the medicine industry since 2006, which shows the determination of the state to solve the trouble in the medicine industry, even if a lot of problems in China's medicine industry have not been solved fundamentally. Meanwhile, the new medicine reform plan will be issued soon, and the integrated thought is to promote the medical hygiene system reform, medical guaranty reform and drug circulation system reform, aiming at establishing the medical insurance system covering China. These measures will solve the existing problems of China's medicine industry with no doubt, as well as release the medical demand of people without medical insurance and the rural population, which will make the whole industry step into the healthier development track.

The medicine industry in China owns a huge market potential, and medical system reform will release the market demand. Currently, the chemical preparations industry in China can not compete with transnational pharmaceutical giants to develop new patent drugs, while the rapid expansion of generic drug market will bring the opportunity for China's chemical preparations companies, so it is a good choice to develop the generic drug. It is trend for the international medicine market transfers the chemical raw material drug production, since China and India have become the best places on the grounds of the lower production cost. Now, it is very important for raw material drug companies in China to seize the favorable historic opportunity.

1 Brief Introduction of Chemical Pharmaceutical Industry 
1.1 History 
1.2 Classification 

2 Status Quo of Global Chemical Pharmaceutical Industry 
2.1 Status Quo 
2.2 Chemical Preparations Industry 
2.3 Chemical Raw Material Drug Industry 
2.4 Development Trend 

3 Status Quo and Future Development of Pharmaceutical Industry in China
3.1 Brief Introduction 
3.2 Environment 
3.2.1 Market 
3.2.2 Policy 
3.3 Forecast of Future Development 

4 Chemical Preparations Industry and Key Companies in China 
4.1 Chemical Preparations Industry 
4.2 Key Companies 

5 Chemical Raw Material Drug Industry and Key Companies in China
5.1 Chemical Raw Material Drug Industry
5.2 Key Companies
Classification of Pharmaceutical Industry 
Sales and Growth Rate of Global Medicine Market, 1970-2006 
Total Output Value of Top Four Global Medicine Markets, 1998-2005 
Global Medicine Market Structure, 2006 
Ratio of Average R&D Investment to Sales by Industry in the World, 2006 
Sales Growth Margin of Patent Drug and Generic Drug in Key Global Markets, 2003 
New Medicine Amount Approved by the USA FDA, 1999-2006 
Product Sales Revenue and Growth Rate of China's Pharmaceutical Industry, 1999-2007 
Sales Ratio of China's Pharmaceutical Industry by Sub-industry, Jan-Aug, 2007 
Amount of Companies and Loss-making Companies of China's Pharmaceutical Industry, 1999-2006 
GDP and Growth Rate in China, 2001-2006
Total Value of Industrial Output and Growth Rate in China, 1999-2005 
Medical & Health Care Expense Structure of Urban Families in China Per Capita, 1999-2005 
Drug Consumption Per Capita in Main Regions and Countries,2005 
Proportion of Urban and Rural Population in China, 1999-2006 
Hygiene Expense of Urban and Rural Population in China, 1990, 1995, 2000 and 2004 
Drug Consumption in Hospital and Drug Stores in China, 2006 
Sum and Proportion of Actual Demand and Virtue Increase Consumption of Hospital Drug Sales, 2006 
Structure of Hygiene Expense in China, 1980-2006 
Number of Persons Participating Basic Urban Medical Care Insurance in China, 2001-2006 
Growth Pace and Forecast by Medicine Market, 2000-2010 
Sales and Growth Rate of Chemical Pharmaceutical Industry in China, 1999-2007 
Sales and Growth Rate of Chemical Raw Material Drug Industry in China, 1999-2007
Regional Distribution of Total Sum of International Trade of China's Raw Material Drug, 2005-2006 
Export by Medicine in China, 2005-2006 

Top Ten Global Medicine Companies by Total Output Value, 2006 
Top Ten Global Drugs, 2006 
Top Ten Global Medicine Companies by R&D Investment, 2006 
Global Merger & Acquisition Cases, 2007 
Top Ten Companies in the USA by Prescription Amount, 2003-2006 
Top Ten Companies in China's Pharmaceutical Industry by Sales Revenue, 2006 
Gross Profit Rate and Net Assets Returning Rate of Key Companies of Chemical Preparations Industry, 2006 
Gross Profit Rate and Net Assets Returning Rate of Key Companies of Chemical Raw Material Drug Industry, 2006 

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统